Gland Pharma Approves Grant of 85,317 Stock Options Under ESOP 2025
Gland Pharma Ltd 路 Others (Uncategorized) 路 16 Nov 2026, 10:52 pm
Gland Pharma Approves Grant of 85,317 Stock Options Under ESOP 2025 Gland Pharma Limited approved the grant of 85,317 employee stock options to two employees on 16th Nov'26 under its ESOP 2025 scheme. The tranche comprises 56,309 options priced at INR 1,692.95 (a 50% discount to NSE closing price on the grant date) and 29,008 options at face value of INR 1.00. The options vest over three years: 34% on 16th Nov'27, 33% on 16th Nov'28, and 33% on 16th Nov'29, with an exercise window of up to two years post-vesting.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
- Unaudited Financial Results for the Quarter and half year ended September 30, 2026 路 06 Nov 2026
